BA
AMED

Boston Advisors’s Amedisys AMED Stock Holding History

Boston Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$6.23M Buy
47,529
+852
+2% +$111K 0.33% 86
2019
Q2 		$5.67M Buy
46,677
+854
+2% +$101K 0.3% 92
2019
Q1 		$5.65M Sell
45,823
-230
-0.5% -$28.9K 0.29% 96
2018
Q4 		$5.39M Buy
46,053
+6,361
+16% +$750K 0.31% 86
2018
Q3 		$4.96M Sell
39,692
-18,158
-31% -$2.01M 0.22% 155
2018
Q2 		$4.94M Buy
57,850
+434
+0.8% +$31.9K 0.12% 176
2018
Q1 		$3.46M Buy
57,416
+5,550
+11% +$316K 0.09% 224
2017
Q4 		$2.73M Buy
51,866
+11,135
+27% +$587K 0.06% 265
2017
Q3 		$2.28M Buy
40,731
+1,354
+3% +$71.6K 0.05% 279
2017
Q2 		$2.47M Buy
39,377
+10,489
+36% +$611K 0.06% 284
2017
Q1 		$1.48M Sell
28,888
-6,429
-18% -$307K 0.03% 307
2016
Q4 		$1.51M Buy
35,317
+246
+0.7% +$10.5K 0.04% 320
2016
Q3 		$1.66M Sell
35,071
-1,616
-4% -$80.6K 0.04% 297
2016
Q2 		$1.85M Buy
36,687
+12,624
+52% +$637K 0.05% 279
2016
Q1 		$1.16M Buy
+24,063
New +$928K 0.03% 309
2013
Q4 		– Sell
-22,976
Closed -$395K – 575
2013
Q3 		$395K Buy
+22,976
New +$341K 0.02% 353

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Boston Advisors's AMED Position: Q3 2019 in Review

Boston Advisors increased its Amedisys (AMED) stake by 1.8% in Q3 2019, buying an estimated $111K and bringing the position to 47,529 shares worth $6.23M. The position accounts for 0.33% of the portfolio, ranked #86.

Boston Advisors first reported a position in AMED in Q3 2013 and has held it in 16 quarters since. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Boston Advisors held 47,529 shares of Amedisys worth $6.23M as of Q3 2019.
  • Boston Advisors bought 852 Amedisys shares in Q3 2019, an estimated $111K.
  • Amedisys made up 0.33% of Boston Advisors's portfolio in Q3 2019, its #86 holding.
  • Boston Advisors first reported a position in Amedisys in Q3 2013 and has held it in 16 quarters since.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.